At XENO we believe biology speaks biology best. Many foundational problems in diagnostics and bioengineering are solvable if biology could just do more of the work. But current biotech isn’t smart enough. We are interested in changing the status quo by systematizing biologic units and constructing modular composition rules. We are a team of engineers and biologists with specialized expertise and common system goals.
Turn Biotechnologies is a Stanford spinout developing therapies to effectively return mature differentiated cells to a dramatically younger state leaving their differentiated identity unaltered. Turn Biotechnologies surpasses traditional approaches based on single gene/pathway manipulations and tackles the multifaceted manifestation of cellular age at the organ, tissue, and organismal level to extend the healthspan of people. As a result, age is reset by epigenetically reprogramming cells.
Aviron Ltd engages in the research and development of specific antiviral agents against chronic Hepatitis C Virus (HCV) infection. The company has strategic alliances with CHEMRAR Hi-Tech Center, Chemical Diversity Research Institute, and DRUGS TECHNOLOGY, Ltd. Aviron Ltd was founded in 2010 and is based in Moscow, Russian Federation.
Provider of workout equipment intended to promote fitness from home. The company's product ranges from tough series rowers with smart resistance, games and several competitions to different workout programs curated by their experienced trainers, enabling customers and clients to avail themselves of a variety of options rather than the traditional boring workout regime.
Framework is a company focused on creating consumer electronics that are environmentally sustainable and user-friendly. The company designs lightweight laptops that prioritize repairability and upgradability, enabling users to customize and assemble their devices without requiring professional assistance. By promoting an open approach to electronics, Framework aims to provide products that are not only better for individual consumers but also for the planet, addressing the growing demand for more sustainable technology solutions.
Operator of an artificial intelligence-driven drug discovery (AIDD) based precision medicine company intended to address metabolic syndrome-related diseases. The company's platform applies systems biology to discover therapeutics and diagnostics for treating metabolic syndrome patients, it combines integrated multi-omics analysis and computational systems biology modeling with targeted wet laboratory experiments to originate novel precision therapeutic concepts that commercialize via partnerships with established biopharma companies, enabling diagnostic companies to get access to new therapeutic and diagnostic research and development programs for subsequent co-developmentmore
Xcell Biosciences, Inc. is a San Francisco-based life science company founded in 2012 that focuses on developing innovative technologies for cancer cell analysis and immunotherapy. The company specializes in a proprietary bench-top system that allows for the capture, growth, and analysis of primary cells directly from patient blood samples. This technology is designed to enhance the control of cell phenotype and function, thereby optimizing the efficacy and persistence of immune cell therapies. By supporting various primary cell types, including immune, stem, and tumor cells, Xcell Biosciences aims to empower researchers with advanced tools for cell maintenance and expansion, ultimately facilitating predictive therapy development and improving clinical outcomes.
Provider of workout equipment intended to promote fitness from home. The company's product ranges from tough series rowers with smart resistance, games and several competitions to different workout programs curated by their experienced trainers, enabling customers and clients to avail themselves of a variety of options rather than the traditional boring workout regime.
Framework is a company focused on creating consumer electronics that are environmentally sustainable and user-friendly. The company designs lightweight laptops that prioritize repairability and upgradability, enabling users to customize and assemble their devices without requiring professional assistance. By promoting an open approach to electronics, Framework aims to provide products that are not only better for individual consumers but also for the planet, addressing the growing demand for more sustainable technology solutions.
Turn Biotechnologies is a Stanford spinout developing therapies to effectively return mature differentiated cells to a dramatically younger state leaving their differentiated identity unaltered. Turn Biotechnologies surpasses traditional approaches based on single gene/pathway manipulations and tackles the multifaceted manifestation of cellular age at the organ, tissue, and organismal level to extend the healthspan of people. As a result, age is reset by epigenetically reprogramming cells.
Nanome Inc., founded in 2015 and based in North Hollywood, California, develops software that enhances scientific research through virtual reality and blockchain technologies. The company focuses on creating an open-source platform that enables scientists to explore molecular structures more effectively. By processing complex molecular data with immersive and collaborative applications, Nanome aids in pattern recognition, molecular visualization, and drug design and discovery. This approach allows medicinal chemists and structural biologists to better understand intricate molecular data and collaborate while protecting their intellectual property through blockchain. By accelerating computational workflows at the molecular scale, Nanome seeks to reduce wasted resources in scientific testing and empower more researchers to utilize advanced molecular computations and artificial intelligence.
BlockFi, Inc. is a financial services company focused on providing wealth management products for cryptocurrency investors. Established in 2017 and headquartered in New York, it offers a range of services including the BlockFi Interest Account, which allows clients to earn interest on their holdings of Bitcoin, Ether, and Gemini Dollar. The company also facilitates secured loans in U.S. dollars, backed by clients' cryptocurrency assets, thereby enhancing liquidity in the blockchain asset market. In addition to lending and interest-earning accounts, BlockFi provides a trading platform for exchanging various cryptocurrency pairs and offers services tailored for institutional clients. By holding clients' digital assets with a registered custodian, BlockFi aims to deliver transparency and efficiency in digital financial markets. The company's mission is to address the evolving needs of both individual and institutional investors in the cryptocurrency space.
Wambi is a developer of a digital management and rewards platform focused on enhancing the quality of care in healthcare settings. Its healthcare recognition platform facilitates workforce management and promotes recognition among staff, which helps to alleviate clinician burnout. By emphasizing compassion and dignity for all individuals involved in healthcare, Wambi aims to improve employee engagement and elevate the overall patient experience. Through its innovative approach, the company seeks to drive significant improvements in key performance indicators for healthcare organizations.
Deep Longevity, Inc. is a biotechnology company focused on advancing the field of aging and longevity through the development of innovative biomarkers and predictive tools. Established in 2016 and headquartered in Hong Kong, the company creates aging clocks and biomarker platforms that utilize various data types, including clinical blood tests, transcriptomic, proteomic, and epigenetic data. Its offerings include Longevity Cloud, which hosts deep aging clocks, and Young.AI, an application designed for tracking biological age and providing recommendations for longevity interventions. Additionally, Deep Longevity produces AgeMetric Reports to help users monitor their biological age over time. By leveraging artificial intelligence, the company aims to enable longevity clinics and healthcare providers to more accurately assess and improve individual health outcomes related to aging.
Angion Biomedica Corp. is a clinical-stage biopharmaceutical company dedicated to the discovery and development of small molecule therapeutics aimed at treating acute organ injuries and fibrotic diseases, particularly focusing on renal conditions. The company is advancing several investigational drugs, including BB3, which is entering phase 3 trials for delayed graft function following kidney transplantation, and phase 2 trials for acute kidney injury associated with open-heart surgery. Additionally, Angion is developing ANG-3070, an orally bioavailable small molecule targeting chronic kidney disease and polycystic kidney disease, along with other programs addressing renal disease and fibrosis, such as ANG-3586 and ANG-4021. Founded in 1998, Angion is headquartered in San Francisco, California, with research and clinical development facilities located in New York and Boston, respectively.
Volumetric, Inc. develops bioprinting platform, which offers 3D bioprinters creating vascularized human tissue. It provides bioprinters and bio inks for applications in the life sciences, drug discovery, and medical devices. The company was incorporated in 2014 and is based in Houston, Texas.
Underdog Pharmaceuticals, Inc. specializes in developing regenerative medicine and direct interventions aimed at treating age-related diseases. Founded in 2019 and headquartered in Mountain View, California, the company focuses on addressing the underlying causes of conditions such as atherosclerosis, hypercholesterolemia, heart failure, and macular degeneration. It employs innovative approaches by targeting toxic forms of cholesterol using rationally designed molecules and novel derivatives of established safe compounds. The company aims to provide the first true disease-modifying treatments for these ailments, reflecting a new perspective on cardiovascular disease inspired by the SENS Research Foundation program.
Gordian Biotechnology, Inc. is focused on developing a screening platform for gene therapy aimed at treating age-related diseases. Established in 2018 and headquartered in San Francisco, California, the company is pioneering a novel discovery platform designed to enhance drug development for complex ailments associated with aging.
Encellin, Inc. is a biotechnology company based in San Francisco, California, founded in 2015. It specializes in developing innovative cell-based therapeutics, particularly focusing on a novel thin-film cell encapsulation device. This device utilizes advanced thin-film cell delivery technology, which encapsulates and replaces cells, allowing the enclosed cells to operate as smart molecular factories. Encellin's primary mission is to provide effective treatments for patients with chronic diseases, with an initial emphasis on Type 1 diabetes. The company is committed to advancing next-generation therapies through the expertise of its dedicated team.
InSilico Medicine, Inc. is an artificial intelligence company focused on drug discovery, biomarker development, and aging research. Founded in 2014 and headquartered in Baltimore, Maryland, the company employs advanced AI technologies, including deep learning and generative adversarial networks, to create novel molecular structures for diseases with known and unknown targets. Its comprehensive platform covers all stages of drug development, from discovery to clinical trials. Key initiatives include Pharma.AI, which offers machine learning services to various industries, and Young.AI, which predicts biological age. InSilico Medicine also engages in internal drug discovery programs targeting conditions such as cancer, Parkinson's Disease, and age-related disorders. Additionally, the company has partnered with Life Extension to develop nutraceutical products using its bioinformatics and deep learning techniques. Through its innovative solutions, InSilico Medicine aims to enhance personalized healthcare and mitigate the effects of aging.
Turn Biotechnologies is a Stanford spinout developing therapies to effectively return mature differentiated cells to a dramatically younger state leaving their differentiated identity unaltered. Turn Biotechnologies surpasses traditional approaches based on single gene/pathway manipulations and tackles the multifaceted manifestation of cellular age at the organ, tissue, and organismal level to extend the healthspan of people. As a result, age is reset by epigenetically reprogramming cells.
InSilico Medicine, Inc. is an artificial intelligence company focused on drug discovery, biomarker development, and aging research. Founded in 2014 and headquartered in Baltimore, Maryland, the company employs advanced AI technologies, including deep learning and generative adversarial networks, to create novel molecular structures for diseases with known and unknown targets. Its comprehensive platform covers all stages of drug development, from discovery to clinical trials. Key initiatives include Pharma.AI, which offers machine learning services to various industries, and Young.AI, which predicts biological age. InSilico Medicine also engages in internal drug discovery programs targeting conditions such as cancer, Parkinson's Disease, and age-related disorders. Additionally, the company has partnered with Life Extension to develop nutraceutical products using its bioinformatics and deep learning techniques. Through its innovative solutions, InSilico Medicine aims to enhance personalized healthcare and mitigate the effects of aging.
Arctoris Limited, founded in 2016 and headquartered in Oxford, United Kingdom, operates the world’s first fully automated drug discovery platform. The company provides an online platform that facilitates data generation, secure storage, analysis, and visualization for researchers and biotech entrepreneurs engaged in cellular and molecular biology experiments. Utilizing advanced robotics and artificial intelligence, Arctoris enables rapid and cost-effective access to a variety of biochemical, cell-based, and molecular biology assays. This automation allows clients, including biotech and pharmaceutical companies as well as academic institutions, to make informed decisions based on high-quality, structured data. By streamlining the drug discovery process, Arctoris aims to accelerate the advancement of new drug programs towards clinical application.
Schrödinger is a healthcare software company that specializes in computational drug design, serving the biopharmaceutical and biotechnology sectors. Founded in 1990, the company operates through two main segments: Software and Drug Discovery. Its software solutions facilitate drug discovery processes for pharmaceutical and industrial clients, as well as academic and governmental research institutions. In addition to software sales, Schrödinger engages in drug discovery through its own preclinical and clinical programs, often collaborating with other organizations. The company is committed to advancing its computational platform by investing in scientific research and talent, and it has established partnerships and collaborations across more than 70 countries. With a workforce of over 400 employees, Schrödinger continues to influence the life sciences and materials science industries through innovative approaches to drug discovery.
Elevian, Inc. is a biotechnology company based in Menlo Park, California, founded in 2017. The company is focused on developing therapeutics aimed at restoring regenerative capacity to prevent and treat age-related diseases. Elevian's research centers on the Growth Differentiation Factor 11 (GDF11) protein and other circulating factors that stimulate regeneration in various tissues, including the brain, heart, pancreas, and muscles. The company's therapeutic candidates target the root causes of aging and aim to address conditions such as stroke recovery, Alzheimer's disease, coronary artery disease, and Type 2 diabetes. By identifying and regulating blood factors that influence aging, Elevian seeks to enable effective treatments that enhance the body’s natural repair and regeneration mechanisms.
Juvenescence Limited is a British Virgin Islands-based holding company focused on investing in human aging and longevity. The company has raised substantial capital to establish a comprehensive ecosystem aimed at addressing aging, age-related diseases, and regeneration. Juvenescence aims to leverage recent scientific advancements to develop therapeutics that can significantly extend human healthspan and lifespan. The company's approach involves creating and partnering with new ventures that specialize in longevity-related therapies, in-licensing promising compounds from academic and industry sources, and collaborating with leading scientists and research institutions. Their work is grounded in a modern understanding of the biological mechanisms of aging, allowing them to create evidence-based treatments for age-associated diseases. Ultimately, Juvenescence seeks to enhance both lifespan and healthspan by developing therapies that slow the aging process and promote rejuvenation.
ZERO specializes in AI-powered email management technology designed specifically for legal professionals. The company automates administrative tasks that often consume valuable time, enabling lawyers to concentrate on their core legal work. Utilizing proprietary machine learning and natural language processing algorithms, ZERO's solutions facilitate the predictive and automatic filing of emails into systems like iManage and NetDocuments. Additionally, the technology captures time spent on emails from mobile devices, generates draft time entry narratives, and detects potential misdirected emails in real-time. By offering these productivity-enhancing features, ZERO helps lawyers streamline their workflows and focus on the most pertinent information in their inboxes.
Bev is a mission-driven alcoholic beverage producer focused on redefining the industry, particularly within traditionally male-dominated spaces. The company specializes in offering a modern cocktail experience through its range of dry canned wines made from quality grapes. These wines feature bright aromatics, including strawberry, raspberry, white peach, and watermelon, while maintaining low sugar and carbohydrate content. This approach allows consumers to enjoy flavored wines that align with contemporary preferences for healthier drinking options.
Iron Ox, Inc. specializes in the development of autonomous robotic greenhouses aimed at producing fresh, pesticide-free farm products. Founded in 2015 and based in San Carlos, California, the company utilizes plant science, machine learning, and robotics to enhance the availability, quality, and flavor of leafy greens and culinary herbs, including varieties such as romaine lettuce, kale, and basil. By focusing on innovative agricultural technology, Iron Ox aims to make naturally grown and chemical-free produce accessible to consumers everywhere.
Anduril Industries is a defense product company that builds technology for military agencies and border surveillance. Anduril commits top technical talent to solving the most complex national security challenges. We’re building the next generation of technology that will aid and protect those who serve on the front lines defending the nation and its interests.
Our mission is to develop cutting edge technology that enables America and its allies to maintain global leadership now and into the future.
Bolt Financial, Inc. is a technology company that specializes in providing a comprehensive checkout experience platform for e-commerce merchants. Founded in 2014 and based in San Francisco, Bolt offers a suite of tools designed to enhance online transactions, including streamlined checkout processes, payment processing, and fraud detection. Key products include Convert, which simplifies the checkout experience; Approve, a system that collects data for order approval and fraud prevention; Collect, a payment processing solution; and Enhance, which delivers shopper analytics and personalized options. By focusing on these technological solutions, Bolt allows retailers to concentrate on growing their brand and customer base while improving the overall shopping experience for consumers.
Prenav, Inc. specializes in developing automated systems for infrastructure inspection, leveraging advanced drone technology and AI. Founded in 2013 and based in San Carlos, California, the company’s innovative platform combines commercial drones, ground guidance robots, and sophisticated software to conduct precise inspections of complex structures such as cell towers, wind turbines, and bridges. Their technology enables drones to navigate with centimeter-level accuracy, allowing for the inspection of critical components like bolts and cabling, while also capturing detailed imagery to create accurate 3D models of industrial assets. This approach significantly enhances safety and efficiency by replacing traditional inspection methods, which often involve climbing or scaffolding, with automated, cost-effective solutions. With a strong team of experts in robotics and computer vision, Prenav is focused on addressing fundamental challenges in the field and expanding its capabilities for various industrial applications.